193 related articles for article (PubMed ID: 19325006)
21. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
Zhao S; Chen X; Lu X; Yu Y; Feng Y
Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
[TBL] [Abstract][Full Text] [Related]
22. Regulation of cell growth of a progestin-dependent murine mammary carcinoma in vitro: progesterone receptor involvement in serum or growth factor-induced cell proliferation.
Lamb C; Simian M; Molinolo A; Pazos P; Lanari C
J Steroid Biochem Mol Biol; 1999; 70(4-6):133-42. PubMed ID: 10622401
[TBL] [Abstract][Full Text] [Related]
23. Anti-proliferative transcriptional effects of medroxyprogesterone acetate in estrogen receptor positive breast cancer cells are predominantly mediated by the progesterone receptor.
Moore NL; Hanson AR; Ebrahimie E; Hickey TE; Tilley WD
J Steroid Biochem Mol Biol; 2020 May; 199():105548. PubMed ID: 31805393
[TBL] [Abstract][Full Text] [Related]
24. Medroxyprogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells.
Pridjian G; Schmit V; Schreiber J
J Steroid Biochem; 1987 Mar; 26(3):313-9. PubMed ID: 2953940
[TBL] [Abstract][Full Text] [Related]
25. Progestins, progesterone receptor modulators, and progesterone antagonists change VEGF release of endometrial cells in culture.
Classen-Linke I; Alfer J; Krusche CA; Chwalisz K; Rath W; Beier HM
Steroids; 2000; 65(10-11):763-71. PubMed ID: 11108887
[TBL] [Abstract][Full Text] [Related]
26. Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
Liang Y; Besch-Williford C; Brekken RA; Hyder SM
Cancer Res; 2007 Oct; 67(20):9929-36. PubMed ID: 17942925
[TBL] [Abstract][Full Text] [Related]
27. Progesterone induction of mammary carcinomas in BALB/c female mice. Correlation between progestin dependence and morphology.
Kordon EC; Molinolo AA; Pasqualini CD; Charreau EH; Pazos P; Dran G; Lanari C
Breast Cancer Res Treat; 1993 Oct; 28(1):29-39. PubMed ID: 8123867
[TBL] [Abstract][Full Text] [Related]
28. Brain-derived neuerotrophic factor and related mechanisms that mediate and influence progesterone-induced neuroprotection.
Singh M; Krishnamoorthy VR; Kim S; Khurana S; LaPorte HM
Front Endocrinol (Lausanne); 2024; 15():1286066. PubMed ID: 38469139
[TBL] [Abstract][Full Text] [Related]
29. Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment.
Helguero LA; Viegas M; Asaithamby A; Shyamala G; Lanari C; Molinolo AA
Breast Cancer Res Treat; 2003 Jun; 79(3):379-90. PubMed ID: 12846422
[TBL] [Abstract][Full Text] [Related]
30. Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement.
Gibbs RB
Brain Res; 1998 Mar; 787(2):259-68. PubMed ID: 9518642
[TBL] [Abstract][Full Text] [Related]
31. Progesterone and neuroprotection.
Singh M; Su C
Horm Behav; 2013 Feb; 63(2):284-90. PubMed ID: 22732134
[TBL] [Abstract][Full Text] [Related]
32. Effects of medroxyprogesterone acetate on cerebral oedema and spatial learning performance after traumatic brain injury in rats.
Wright DW; Hoffman SW; Virmani S; Stein DG
Brain Inj; 2008 Feb; 22(2):107-13. PubMed ID: 18240039
[TBL] [Abstract][Full Text] [Related]
33. Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells.
Zerr-Fouineau M; Jourdain M; Boesch C; Hecker M; Bronner C; Schini-Kerth VB
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):586-93. PubMed ID: 19096000
[TBL] [Abstract][Full Text] [Related]
34. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
[TBL] [Abstract][Full Text] [Related]
35. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
Altinoz MA; Ozpinar A; Elmaci I
Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
[TBL] [Abstract][Full Text] [Related]
36. Progestins regulate genes that can elicit both proliferative and antiproliferative effects in breast cancer cells.
Purmonen S; Manninen T; Pennanen P; Ylikomi T
Oncol Rep; 2008 Jun; 19(6):1627-34. PubMed ID: 18497975
[TBL] [Abstract][Full Text] [Related]
37. Binding specificity of medroxyprogesterone acetate and proligestone for the progesterone and glucocorticoid receptor in the dog.
Selman PJ; Wolfswinkel J; Mol JA
Steroids; 1996 Mar; 61(3):133-7. PubMed ID: 8852830
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
Courtin A; Communal L; Vilasco M; Cimino D; Mourra N; de Bortoli M; Taverna D; Faussat AM; Chaouat M; Forgez P; Gompel A
Breast Cancer Res Treat; 2012 Jan; 131(1):49-63. PubMed ID: 21336598
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A).
Africander DJ; Storbeck KH; Hapgood JP
J Steroid Biochem Mol Biol; 2014 Sep; 143():404-15. PubMed ID: 24861265
[TBL] [Abstract][Full Text] [Related]
40. Progesterone and medroxyprogesterone acetate differentially regulate alpha4 subunit expression of GABA(A) receptors in the CA1 hippocampus of female rats.
Pazol K; Northcutt KV; Patisaul HB; Wallen K; Wilson ME
Physiol Behav; 2009 Apr; 97(1):58-61. PubMed ID: 19394921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
